Combivent

Combivent: Combined bronchodilator

Combivent is a combination bronchodilator developed to treat diseases of the respiratory system such as chronic obstructive pulmonary disease (COPD) and asthma. It contains two active ingredients: salbutamol and ipratropium bromide. Salbutamol is a bronchodilator that dilates the bronchi and makes breathing easier, and ipratropium bromide is an anticholinergic that reduces mucus secretion and bronchial muscle spasms.

Combivent is produced by the pharmaceutical company Boehringer Ingelheim in France. This company is known for its high quality products and commitment to innovation in the field of medicine. Thanks to its experience and research, Boehringer Ingelheim created Combivent as an effective remedy for relieving the symptoms of diseases of the respiratory system.

Combivent is available in 200-dose aerosol form. It is convenient and easy to use and provides precise dosage for each inhalation. Patients can use an aerosol inhaler to deliver medication directly to the lungs, where it works quickly and makes breathing easier.

The use of Combivent helps control symptoms of asthma and COPD, such as shortness of breath, difficulty breathing and chest tightness. Combivent improves patients' quality of life by allowing them to actively participate in daily activities without having to worry about shortness of breath.

It is important to note that the use of Combivent should be under the supervision of a physician. Only a doctor can determine the correct dosage and regimen of use, taking into account the individual characteristics of the patient.

In conclusion, Combivent is an effective combination bronchodilator manufactured by the French company Boehringer Ingelheim. The combination of salbutamol and ipratropium bromide provides relief from symptoms of asthma and COPD, allowing patients to breathe easier and improve their quality of life. When using Combivent, it is important to follow your doctor's recommendations and use the correct dosage for best results.